Sustainable Growth Advisers LP lessened its position in Danaher Corporation (NYSE:DHR – Free Report) by 16.7% during the fourth quarter, Holdings Channel.com reports. The fund owned 1,597,798 shares of the conglomerate’s stock after selling 320,143 shares during the period. Danaher accounts for 2.5% of Sustainable Growth Advisers LP’s holdings, making the stock its 16th largest holding. Sustainable Growth Advisers LP’s holdings in Danaher were worth $365,768,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in DHR. Capital International Investors boosted its stake in shares of Danaher by 1.9% during the 3rd quarter. Capital International Investors now owns 16,758,240 shares of the conglomerate’s stock valued at $3,318,926,000 after purchasing an additional 312,951 shares in the last quarter. Norges Bank bought a new stake in shares of Danaher during the 4th quarter valued at about $2,177,106,000. Generation Investment Management LLP boosted its stake in shares of Danaher by 34.0% during the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock valued at $1,319,354,000 after purchasing an additional 1,689,020 shares in the last quarter. Legal & General Group Plc boosted its stake in shares of Danaher by 1.0% during the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after purchasing an additional 43,169 shares in the last quarter. Finally, Fisher Asset Management LLC boosted its stake in shares of Danaher by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,446,976 shares of the conglomerate’s stock valued at $1,018,002,000 after purchasing an additional 77,757 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
Danaher Stock Down 1.4%
Shares of Danaher stock opened at $180.07 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock has a market capitalization of $127.45 billion, a PE ratio of 34.83, a price-to-earnings-growth ratio of 2.44 and a beta of 0.81. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a 50-day simple moving average of $181.91 and a two-hundred day simple moving average of $207.20.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s payout ratio is 30.95%.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the stock. UBS Group lowered their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a research report on Friday, April 17th. Citigroup assumed coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Finally, Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday. Nineteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $238.24.
Get Our Latest Analysis on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
